Leadership News,
Insights & Events

GlaxoSmithKline | Boss faces ousting by 'activist investors' - here's why leaders should be worried

Boss faces ousting by 'activist investors' - here's why leaders should be worried

One of GlaxoSmithKline's smaller investors is currently looking to oust its CEO.

Whilst they may not seem to be a threat, Exxon was recently overruled by a similar group. They part of a new wave of 'activist investors', looking to shape the future of business. Will they be successful? Read on to find out...

Create a FREE account to access this content.

You can access this article and lots more with a free myGrapevine account.

  • Create a personalised content feed around the topics that matter most to you.
  • Read news and features from across all our websites.
  • Get exclusive content only available to account holders.

Welcome Back